In contrast, in cervical cancer, PRMT5 promotes cancer progression by increasing the expression of histone H3R2 symmetric dimethylation (H3R2me2s), which is enriched in the promoter region of STAT1 to enhance transcription and drive up-regulation of PD-L1 expression (86). Here, CD274 is linked to cervical cancer.